Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Biorestorative Therapies, Inc. stock logo
BRTX
Biorestorative Therapies
$1.58
-0.4%
$1.72
$1.21
$2.55
$11.63M75.28142,735 shs43,517 shs
BioRestorative Therapies, Inc. stock logo
BRTXQ
BioRestorative Therapies
$1.55
-2.5%
$1.72
$0.00
$0.06
$2.54B102.3662.17 million shs43,517 shs
American Caresource Holdings Inc. stock logo
GNOW
American Caresource
$0.00
$0.00
$0.00
N/AN/AN/AN/A
Hybrid Energy Holdings Inc. stock logo
HYBE
Hybrid Energy
$0.00
$0.00
$0.00
N/A12.67N/AN/A
Pacific Health Care Organization Inc. stock logo
PFHO
Pacific Health Care Organization
$0.80
$0.83
$0.65
$0.99
$10.24M-0.0321,061 shsN/A
These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Biorestorative Therapies, Inc. stock logo
BRTX
Biorestorative Therapies
0.00%-1.61%-10.25%-8.17%-15.29%
BioRestorative Therapies, Inc. stock logo
BRTXQ
BioRestorative Therapies
-2.52%-7.19%-12.92%-8.83%-19.27%
American Caresource Holdings Inc. stock logo
GNOW
American Caresource
0.00%0.00%0.00%0.00%0.00%
Hybrid Energy Holdings Inc. stock logo
HYBE
Hybrid Energy
0.00%0.00%0.00%0.00%0.00%
Pacific Health Care Organization Inc. stock logo
PFHO
Pacific Health Care Organization
0.00%0.00%-3.33%+11.11%-9.09%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Biorestorative Therapies, Inc. stock logo
BRTX
Biorestorative Therapies
2.7696 of 5 stars
3.53.00.00.00.63.30.6
BioRestorative Therapies, Inc. stock logo
BRTXQ
BioRestorative Therapies
N/AN/AN/AN/AN/AN/AN/AN/A
American Caresource Holdings Inc. stock logo
GNOW
American Caresource
N/AN/AN/AN/AN/AN/AN/AN/A
Hybrid Energy Holdings Inc. stock logo
HYBE
Hybrid Energy
N/AN/AN/AN/AN/AN/AN/AN/A
Pacific Health Care Organization Inc. stock logo
PFHO
Pacific Health Care Organization
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Biorestorative Therapies, Inc. stock logo
BRTX
Biorestorative Therapies
3.00
Buy$18.001,036.36% Upside
BioRestorative Therapies, Inc. stock logo
BRTXQ
BioRestorative Therapies
0.00
N/AN/AN/A
American Caresource Holdings Inc. stock logo
GNOW
American Caresource
0.00
N/AN/AN/A
Hybrid Energy Holdings Inc. stock logo
HYBE
Hybrid Energy
0.00
N/AN/AN/A
Pacific Health Care Organization Inc. stock logo
PFHO
Pacific Health Care Organization
0.00
N/AN/AN/A

Current Analyst Ratings Breakdown

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Biorestorative Therapies, Inc. stock logo
BRTX
Biorestorative Therapies
$400K29.70N/AN/A$1.23 per share1.29
BioRestorative Therapies, Inc. stock logo
BRTXQ
BioRestorative Therapies
$110K23,103.82N/AN/A($0.68) per share-2.28
American Caresource Holdings Inc. stock logo
GNOW
American Caresource
N/AN/AN/AN/AN/AN/A
Hybrid Energy Holdings Inc. stock logo
HYBE
Hybrid Energy
N/AN/AN/AN/AN/AN/A
Pacific Health Care Organization Inc. stock logo
PFHO
Pacific Health Care Organization
$6.07M1.69$0.07 per share11.15$0.91 per share0.88
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Biorestorative Therapies, Inc. stock logo
BRTX
Biorestorative Therapies
-$8.98M-$1.47N/AN/AN/A-3,093.61%-129.47%-86.02%8/12/2025 (Estimated)
BioRestorative Therapies, Inc. stock logo
BRTXQ
BioRestorative Therapies
-$12.52M-$1.07N/AN/AN/AN/AN/AN/A
American Caresource Holdings Inc. stock logo
GNOW
American Caresource
N/AN/A0.00N/AN/AN/AN/AN/AN/A
Hybrid Energy Holdings Inc. stock logo
HYBE
Hybrid Energy
N/AN/A0.00N/AN/AN/AN/AN/AN/A
Pacific Health Care Organization Inc. stock logo
PFHO
Pacific Health Care Organization
$880K$0.0711.43N/A15.18%8.47%7.97%8/5/2025 (Estimated)

Latest BRTX, BRTXQ, PFHO, GNOW, and HYBE Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/14/2025Q1 2025
Biorestorative Therapies, Inc. stock logo
BRTX
Biorestorative Therapies
-$0.32-$0.56-$0.24-$0.64$0.38 million$0.03 million
5/2/2025Q1 2025
Pacific Health Care Organization Inc. stock logo
PFHO
Pacific Health Care Organization
N/A$0.02N/A$0.02N/A$1.82 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Biorestorative Therapies, Inc. stock logo
BRTX
Biorestorative Therapies
N/AN/AN/AN/AN/A
BioRestorative Therapies, Inc. stock logo
BRTXQ
BioRestorative Therapies
N/AN/AN/AN/AN/A
American Caresource Holdings Inc. stock logo
GNOW
American Caresource
N/AN/AN/AN/AN/A
Hybrid Energy Holdings Inc. stock logo
HYBE
Hybrid Energy
N/AN/AN/AN/AN/A
Pacific Health Care Organization Inc. stock logo
PFHO
Pacific Health Care Organization
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Biorestorative Therapies, Inc. stock logo
BRTX
Biorestorative Therapies
N/A
2.24
2.24
BioRestorative Therapies, Inc. stock logo
BRTXQ
BioRestorative Therapies
N/AN/AN/A
American Caresource Holdings Inc. stock logo
GNOW
American Caresource
N/AN/AN/A
Hybrid Energy Holdings Inc. stock logo
HYBE
Hybrid Energy
N/AN/AN/A
Pacific Health Care Organization Inc. stock logo
PFHO
Pacific Health Care Organization
N/A
18.55
18.55
CompanyEmployeesShares OutstandingFree FloatOptionable
Biorestorative Therapies, Inc. stock logo
BRTX
Biorestorative Therapies
77.50 million5.59 millionNot Optionable
BioRestorative Therapies, Inc. stock logo
BRTXQ
BioRestorative Therapies
71.64 billionN/ANot Optionable
American Caresource Holdings Inc. stock logo
GNOW
American Caresource
20N/AN/ANot Optionable
Hybrid Energy Holdings Inc. stock logo
HYBE
Hybrid Energy
1N/AN/ANot Optionable
Pacific Health Care Organization Inc. stock logo
PFHO
Pacific Health Care Organization
3012.80 million4.92 millionNot Optionable

Recent News About These Companies

PAHO insists on the importance of universal access to care
PAHO warns of increase in yellow fever cases
PAHO warns of NCDs spreading in the region
Waipahu High School offers hands-on health care training
Metro Pacific Health, mWell ink referral partnership
DLR Group Appoints Healthcare Design Project Leader for Pacific Northwest

New MarketBeat Followers Over Time

Media Sentiment Over Time

Biorestorative Therapies stock logo

Biorestorative Therapies NASDAQ:BRTX

$1.58 -0.01 (-0.38%)
As of 07/3/2025 03:35 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

BioRestorative Therapies, Inc., a life sciences company, focuses on the development of regenerative medicine products and therapies using cell and tissue protocols primarily involving adult stem cells. The company's two core developmental programs relate to the treatment of disc/spine disease and metabolic disorders. Its disc/spine program (brtxDisc) includes a lead cell therapy candidate, BRTX-100, a product candidate formulated from autologous cultured mesenchymal stem cells collected from the patient's bone marrow, which has completed Phase 1 clinical trials for use in the non-surgical treatment of painful lumbosacral disc disorders. The company is also developing Metabolic Program (ThermoStem), a cell-based therapy candidate that is in preclinical stage to target obesity and metabolic disorders using brown adipose derived stem cells to generate brown adipose tissue. In addition, it provides investigational curved needle device designed to deliver cells and/or other therapeutic products or material to the spine and discs. BioRestorative Therapies, Inc. has a research and development agreement with Rohto Pharmaceutical Co., Ltd.; a research agreement with Pfizer, Inc.; and a research collaboration agreement with the University of Pennsylvania. The company was formerly known as Stem Cell Assurance, Inc. and changed its name to BioRestorative Therapies, Inc. in August 2011. The company was incorporated in 1997 and is based in Melville, New York.

BioRestorative Therapies stock logo

BioRestorative Therapies OTCMKTS:BRTXQ

$1.55 -0.04 (-2.52%)
As of 07/3/2025

BioRestorative Therapies, Inc. develops therapeutic products using cell and tissue protocols primarily involving adult stem cells. The company's two core programs are related to the treatment of disc/spine disease and metabolic disorders. Its disc/spine program includes a lead cell therapy candidate, BRTX-100 is a product formulated from autologous (or a person's own) cultured mesenchymal stem cells collected from the patient's bone marrow and intended for the non-surgical treatment of painful lumbosacral disc disorders. The BRTX-100 utilizes proprietary technology and involves collecting a patient's bone marrow, isolating and culturing stem cells from the bone marrow, and cryopreserving the cells. In an outpatient procedure, BRTX-100 is to be injected by a physician into the patient's damaged disc and treatment is intended for patients whose pain has not been alleviated by non-invasive procedures and who potentially face the prospect of surgery. The company have received authorization from the Food and Drug Administration to commence a Phase 2 clinical trial using BRTX-100to treat persistent lower back pain due to painful degenerative discs. The company is also developing Metabolic Program (ThermoStem), a cell-based therapy in preclinical stage to target obesity and metabolic disorders using brown adipose (fat) derived stem cells to generate brown adipose tissue (BAT). In addition, the company provides investigational curved needle device designed to deliver cells and/or other therapeutic products or material to the spine and discs. BioRestorative Therapies, Inc. has a research and development agreement with Rohto Pharmaceutical Co., Ltd.; and a research agreement with Pfizer, Inc. and the University of Pennsylvania. The company was formerly known as Stem Cell Assurance, Inc. and changed its name to BioRestorative Therapies, Inc. in August 2011. BioRestorative Therapies, Inc. was incorporated in 1997 and is based in Melville, New York. On March 20, 2020, BioRestorative Therapies, Inc., filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the Eastern District of New York.

American Caresource stock logo

American Caresource OTCMKTS:GNOW

American CareSource Holdings, Inc. provides urgent and primary care services in the United States. The company operates healthcare centers that offer non-life-threatening out-patient medical care for the treatment of acute, episodic, and chronic medical conditions. Its healthcare centers provide treatment of general medical problems, including colds, flus, ear infections, hypertension, asthma, pneumonia, urinary tract infections, and other conditions; treatment of injuries, such as fractures, dislocations, sprains, bruises, and cuts; minor non-emergent surgical procedures; diagnostic tests, such as X-rays, electrocardiograms, complete blood counts, and urinalyses; and occupational and industrial medical services, including drug testing, workers' compensation cases, and pre-employment physical examinations. It owns and operates 13 urgent and primary care centers, including 2 in Georgia, 2 in Florida, 3 in Alabama, 4 in North Carolina, and 2 in Virginia. The company was founded in 1995 and is headquartered in Atlanta, Georgia.

Hybrid Energy stock logo

Hybrid Energy OTCMKTS:HYBE

Hybrid Energy Holdings, Inc., through its subsidiaries, acquires and operates fuel production and other energy companies. It acquires companies with traditional and proven fuel production, photovoltaic (PV) and solar thermal technologies. Hybrid Energy Holdings, Inc. was formerly known as Comprehensive Healthcare Solutions, Inc. and changed its name to Hybrid Energy Holdings, Inc. in September 2009. Hybrid Energy Holdings, Inc. was incorporated in 1966 and is based in Reno, Nevada. Hybrid Energy Holdings, Inc. is in reorganization.

Pacific Health Care Organization stock logo

Pacific Health Care Organization OTCMKTS:PFHO

$0.80 0.00 (0.00%)
As of 07/1/2025

Pacific Health Care Organization, Inc., together with its subsidiaries, operates as a specialty workers' compensation cost containment company in the United States. It is involved in managing and administering health care organizations (HCOs) and medical provider networks (MPNs). The company also provides claims-related services, including utilization review, medical case management, medical bill review, employee advocate services, workers' compensation carve-outs, expert witness testimony, and Medicare set-aside services. It serves insurers, third party administrators, self-administered employers, municipalities, and other industries. The company was formerly known as Clear Air, Inc. and changed its name to Pacific Health Care Organization, Inc. in January 2001. Pacific Health Care Organization, Inc. was incorporated in 1970 and is based in Irvine, California.